檢索結果 - Gurwith, Marc
- Showing 1 - 20 results of 42
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus 由 Hernandez, Libia Milena, Sumathy, K., Sahastrabuddhe, Sushant, Excler, Jean-Louis, Kochhar, Sonali, Smith, Emily R., Gurwith, Marc, Chen, Robert T.
出版 2022Text -
12
Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization 由 Khurana, Surender, Coyle, Elizabeth M., Manischewitz, Jody, King, Lisa R., Ishioka, Glenn, Alexander, Jeff, Smith, Jon, Gurwith, Marc, Golding, Hana
出版 2015Text -
13
-
14
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273) 由 Leav, Brett, Straus, Walter, White, Phil, Leav, Alison, Gaines, Tashawnee, Maggiacomo, Grace, Kim, Denny, Smith, Emily R., Gurwith, Marc, Chen, Robert T.
出版 2022Text -
15
Live Adenovirus Type 4 Recombinants Induce Durable Neutralizing Antibody Responses to Influenza H5 with High Levels of Somatic Hypermutation in Humans 由 Huang, Jinghe, Kang, Byong, Wheatley, Adam, Narpala, Sandeep, Mcdermott, Adrian, Poole, April, Bailer, Robert, Koup, Richard, Migueles, Stephen, Gurwith, Marc, Connors, Mark
出版 2014Text -
16
Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment 由 Folegatti, Pedro M, Jenkin, Daniel, Morris, Susan, Gilbert, Sarah, Kim, Denny, Robertson, James S., Smith, Emily R., Martin, Emalee, Gurwith, Marc, Chen, Robert T.
出版 2022Text -
17
Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study 由 Gurwith, Marc, Lock, Michael, Taylor, Eve M, Ishioka, Glenn, Alexander, Jeff, Mayall, Tim, Ervin, John E, Greenberg, Richard N, Strout, Cynthia, Treanor, John J, Webby, Richard, Wright, Peter F
出版 2013Text -
18
Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines 由 Kochhar, Sonali, Excler, Jean-Louis, Bok, Karin, Gurwith, Marc, McNeil, Michael M., Seligman, Stephen J., Khuri-Bulos, Najwa, Klug, Bettina, Laderoute, Marian, Robertson, James S., Singh, Vidisha, Chen, Robert T.
出版 2019Text -
19
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines 由 Condit, Richard C, Kim, Denny, Robertson, James S., Excler, Jean-Louis, Gurwith, Marc, Monath, Thomas P., Pavlakis, George, Fast, Patricia E., Smith, Jonathan, Smith, Emily R., Chen, Robert T., Kochhar, Sonali
出版 2020Text -
20
Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge 由 Espinosa, Diego, Mendy, Jason, Manayani, Darly, Vang, Lo, Wang, Chunling, Richard, Tiffany, Guenther, Ben, Aruri, Jayavani, Avanzini, Jenny, Garduno, Fermin, Farness, Peggy, Gurwith, Marc, Smith, Jon, Harris, Eva, Alexander, Jeff
出版 2017Text